DOI: 10.1055/s-00000175

Arzneimittelforschung

LinksClose Window

References

FDA.
Guidance for Industry Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency.
2008; 1-17

Download Bibliographical Data

Search in:

We do not assume any responsibility for the contents of the web pages of other providers.